Progyny (PGNY) reported $304.09 million in revenue for the quarter ended June 2024, representing a yearover-year increase of 8.9%. EPS of $0.43 for the same period compares to $0.15 a year ago. The reported revenue represents a surprise of -1.41% over the Zacks Consensus Estimate of $308.43 million. With the consensus EPS estimate being $0.36, the EPS surprise was +19.44%. While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street ...

Progyny (PGNY) came out with quarterly earnings of $0.43 per share, beating the Zacks Consensus Estimate of $0.36 per share. This compares to earnings of $0.15 per share a year ago. These figures are adjusted for nonrecurring items. This quarterly report represents an earnings surprise of 19.44%. A quarter ago, it was expected that this provider of fertility and family building benefits would post earnings of $0.14 per share when it actually produced earnings of $0.39, delivering a surprise of 178.57%. Over ...

The company will host a conference call at 4:45 P.M. Eastern Time (1:45 P.M. Pacific Time) and issue a press release regarding its financial results prior to the start of the call. Interested participants in the United States may access the conference call by dialing 1.866.825.7331 and using the passcode 265484. International participants may access the call by dialing 1.973.413.6106 and using the same passcode. An audio replay of the call will be available through Tuesday, August 13, 2024 and may be access ...

Dublin, July 12, 2024 (GLOBE NEWSWIRE) -- The "Assisted Reproductive Technology Global Market Opportunities and Strategies to 2033" report has been added to ResearchAndMarkets.com's offering. Where is the largest and fastest-growing market for assisted reproductive technology? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? This report answers all these questions and many more. 0 Going forward, the technological develo ...

Media: Selena Yang media@progyny.com NEW YORK, June 26, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women's health benefits solution, today announced that it will host its inaugural Investor Day in New York City on Monday, August 12, 2024, from 9:00 A.M. Eastern Time until approximately 1:00 P.M. Eastern Time. Progyny's executives, along with other members of the senior leadership team, will present an overview of the Company's business and its gro ...

NEW YORK, June 26, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women's health benefits solution, today announced that it will host its inaugural Investor Day in New York City on Monday, August 12, 2024, from 9:00 A.M. Eastern Time until approximately 1:00 P.M. Eastern Time. Progyny's executives, along with other members of the senior leadership team, will present an overview of the Company's business and its growth opportunities. During the meeting ...

NEW YORK, June 24, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women's health benefits solution, today announced an expansion of its global offering with the acquisition of Apryl, a Berlin-based fertility benefits platform founded in 2019. This acquisition enhances Progyny's guided, concierge support that enables employees around the world to navigate the complexities of fertility and family building care. Progyny's global benefits solution support ...

Progyny's global benefits solution supports multinational employers and their employee populations in over 100 countries. Progyny's services allow employers the flexibility to offer fertility and family building benefits that comply with the intricacies of country-specific laws and regulations as it relates to fertility and family building services, treatments, and benefit design. Progyny's enhanced global services include: Jenny Saft, co-founder of Apryl, said, "We saw the incredible solution and impact Pr ...

NEW YORK, June 11, 2024 /PRNewswire/ -- Kindbody, the leading national fertility clinic network and global family-building benefits provider for employers, today announced its Founder and Executive Chairman, Gina Bartasi, will return as the company's CEO during a time of unprecedented growth. The Company recently shared that it expected to deliver revenue in the range of $225-$250 million for 2024 and is now profitable after years of significant investment into new clinic locations and proprietary technolog ...

Progyny (NASDAQ:PGNY) has not received much love lately after reporting a topline miss in their Q1 2024 call on May 9th, with the stock dropping around 15%. Management attributed the miss to a decline in utilization rates that coincided with an Alabama's supreme court ruling that embryos should have the same legal rights as persons. The utilization decline was more pronounced in red states, according to management. Yet, the long-term prospects remain stable in my opinion. Two secular tailwinds present signi ...